rts logo

Who are the Institutional Holders in Leap Therapeutics Inc (LPTX)?

Leap Therapeutics Inc (NASDAQ: LPTX) is -27.86% lower on its value in year-to-date trading and has touched a low of $1.68 and a high of $5.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LPTX stock was last observed hovering at around $3.07 in the last trading session, with the day’s loss setting it -0.08%.

Currently trading at $2.99, the stock is 3.32% and 1.84% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.27 million and changing -2.61% at the moment leaves the stock 13.29% off its SMA200. LPTX registered 9.93% gain for a year compared to 6-month gain of 32.89%. The firm has a 50-day simple moving average (SMA 50) of $2.9283 and a 200-day simple moving average (SMA200) of $2.639235.

The stock witnessed a -15.77% loss in the last 1 month and extending the period to 3 months gives it a 6.41%, and is 2.40% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.80% over the week and 9.98% over the month.

Leap Therapeutics Inc (LPTX) has around 54 employees, a market worth around $114.57M and $0.00M in sales. Distance from 52-week low is 77.98% and -40.20% from its 52-week high. The company has generated returns on investments over the last 12 months (-131.94%).

The EPS is expected to grow by 53.42% this year

56.0 institutions hold shares in Leap Therapeutics Inc (LPTX), with institutional investors hold 48.73% of the company’s shares. The shares outstanding are 38.26M, and float is at 28.55M with Short Float at 4.99%. Institutions hold 40.30% of the Float.

Related Posts